These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33726915)

  • 1. Radiological management and follow-up of post-COVID-19 patients.
    Alarcón-Rodríguez J; Fernández-Velilla M; Ureña-Vacas A; Martín-Pinacho JJ; Rigual-Bobillo JA; Jaureguízar-Oriol A; Gorospe-Sarasúa L
    Radiologia (Engl Ed); 2021; 63(3):258-269. PubMed ID: 33726915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiological management and follow-up of post-COVID-19 patients].
    Alarcón-Rodríguez J; Fernández-Velilla M; Ureña-Vacas A; Martín-Pinacho JJ; Rigual-Bobillo JA; Jaureguízar-Oriol A; Gorospe-Sarasúa L
    Radiologia; 2021; 63(3):258-269. PubMed ID: 35370314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19.
    Dhawan RT; Gopalan D; Howard L; Vicente A; Park M; Manalan K; Wallner I; Marsden P; Dave S; Branley H; Russell G; Dharmarajah N; Kon OM
    Lancet Respir Med; 2021 Jan; 9(1):107-116. PubMed ID: 33217366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.
    Picchi G; Mari A; Ricciardi A; Carucci AC; Sinatti G; Cosimini B; Di Norcia M; Iapadre N; Balsano C; Grimaldi A
    Am J Case Rep; 2020 Nov; 21():e926921. PubMed ID: 33219200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19.
    Han X; Fan Y; Alwalid O; Zhang X; Jia X; Zheng Y; Shi H
    Radiology; 2021 Dec; 301(3):E438-E440. PubMed ID: 34313470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual lesions on chest-Xray after SARS-CoV-2 pneumonia: Identification of risk factors.
    Gómez Herrero H; Galbete A; Álvarez Galván B; Caballero García P; Vicaría Fernández I
    Med Clin (Barc); 2022 May; 158(9):418-421. PubMed ID: 34059358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of pulmonary residuals as one of the sequelae of COVID-19 and it's predictors among moderate and severe cases.
    Abdel-Hamid HM; Rizk HI; Magdy S
    Indian J Tuberc; 2021 Oct; 68(4):450-456. PubMed ID: 34752312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up of patients after COVID-19 pneumonia. Pulmonary sequelae].
    Chérrez-Ojeda I; Gochicoa-Rangel L; Salles-Rojas A; Mautong H
    Rev Alerg Mex; 2020; 67(4):350-369. PubMed ID: 33631903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term respiratory complications of covid-19.
    Fraser E
    BMJ; 2020 Aug; 370():m3001. PubMed ID: 32747332
    [No Abstract]   [Full Text] [Related]  

  • 10. Olfactory function and findings on chest computed tomography in COVID-19: is there any correlation?
    Mangia LRL; Soares MB; de Souza TSC; Scarabotto PC; De Masi RDJ; Salvador GLO; Hamerschmidt R
    Acta Otolaryngol; 2021 Mar; 141(3):293-298. PubMed ID: 33346687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Fibrosis Sequelae After Recovery from COVID-19 Infection.
    Susanto AD; Triyoga PA; Isbaniah F; Fairuz A; Cendikiawan H; Zaron F; Aryanti I; Irbah SN; Hidayat M
    J Infect Dev Ctries; 2021 Mar; 15(3):360-365. PubMed ID: 33839710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
    Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
    Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of risk factors for radiological sequelae in patients treated for pulmonary tuberculosis: Prospective observational cohort study.
    Kumar Rai D; Kumar R
    Indian J Tuberc; 2020 Oct; 67(4):534-538. PubMed ID: 33077056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis.
    Aul DR; Gates DJ; Draper DA; Dunleavy DA; Ruickbie DS; Meredith DH; Walters DN; van Zeller DC; Taylor DV; Bridgett DM; Dunwoody DR; Grubnic DS; Jacob DT; Ean Ong DY
    Respir Med; 2021 Nov; 188():106602. PubMed ID: 34536697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are there pulmonary sequelae in patients recovering from COVID-19?
    Rogliani P; Calzetta L; Coppola A; Puxeddu E; Sergiacomi G; D'Amato D; Orlacchio A
    Respir Res; 2020 Oct; 21(1):286. PubMed ID: 33126869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis.
    Fabbri L; Moss S; Khan FA; Chi W; Xia J; Robinson K; Smyth AR; Jenkins G; Stewart I
    Thorax; 2023 Feb; 78(2):191-201. PubMed ID: 35338102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
    Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C
    J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial findings in chest X-rays as predictors of worsening lung infection in patients with COVID-19: correlation in 265 patients.
    Petite Felipe DJ; Rivera Campos MI; San Miguel Espinosa J; Malo Rubio Y; Flores Quan JC; Cuartero Revilla MV
    Radiologia (Engl Ed); 2021; 63(4):324-333. PubMed ID: 34246423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-based pulmonary rehabilitation for a post-COVID-19 pulmonary fibrosis patient: A case report.
    Choi K; Kim M; Lee SM; Kim J
    Medicine (Baltimore); 2021 Nov; 100(47):e27980. PubMed ID: 34964792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.
    Yim J; Lim HH; Kwon Y
    Arch Pharm Res; 2021 May; 44(5):499-513. PubMed ID: 34047940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.